NCT02381548 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02381548
Title	Phase I Trial of AZD1775 and Belinostat in Treating Patients With Relapsed or Refractory Myeloid Malignancies or Untreated Acute Myeloid Leukemia
Recruitment	Terminated
Gender	both
Phase	Phase I
Variant Requirements	Yes
Sponsors	National Cancer Institute (NCI)
Indications	chronic myeloid leukemia acute myeloid leukemia bone marrow cancer
Therapies	Adavosertib + Belinostat
Age Groups:	adult
Covered Countries	USA

Facility	Status	City	State	Zip	Country	Details
Moffitt Cancer Center		Tampa	Florida	33612	United States	Details
VCU Massey Comprehensive Cancer Center		Richmond	Virginia	23298	United States	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT02381548Clinical Trial Detail